|
1
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wiersinga WJ, Rhodes A, Cheng AC, Peacock
SJ and Prescott HC: Pathophysiology, transmission, diagnosis, and
treatment of coronavirus disease 2019 (COVID-19): A review. JAMA.
324:782–793. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Xu Z, Shi L, Wang Y, Zhang J, Huang L,
Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings
of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Siddiqi HK and Mehra MR: COVID-19 illness
in native and immunosuppressed states: A clinical-therapeutic
staging proposal. J Hear Lung Transplant. 39:405–407.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lin L and Li TS: Interpretation of
‘guidelines for the diagnosis and treatment of novel coronavirus
(2019-nCoV) infection by the national health commission (trial
version 5)’. Zhonghua Yi Xue Za Zhi. 100:805–807. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese),
(Online ahead of print).
|
|
7
|
COVID-19 Treatment Guidelines Panel:
Coronavirus disease 2019 (COVID-19) treatment guidelines. National
Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov/.
Accessed June 15, 2021.
|
|
8
|
ARDS Definition Task Force. Ranieri VM,
Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L and Slutsky AS: Acute respiratory distress syndrome:
The Berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Martínez Chamorro E, Díez Tascón A, Ibáñez
Sanz L, Ossaba Vélez S and Borruel Nacenta S: Radiologic diagnosis
of patients with COVID-19. Radiologia (Engl Ed). 63:56–73.
2021.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
10
|
Knaus WA, Draper EA, Wagner DP and
Zimmerman JE: Apache II. A severity of disease classification
system. Crit Care Med. 13:818–829. 1985.PubMed/NCBI
|
|
11
|
Franchini M and Liumbruno GM: Convalescent
plasma for the treatment of severe COVID-19. Biologics. 15:31–38.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang
J, Kong Y, Ren L, Wei Q, Mei H, et al: Effect of convalescent
plasma therapy on time to clinical improvement in patients with
severe and life-threatening COVID-19: A randomized clinical trial.
JAMA. 324:460–470. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Keith P, Day M, Perkins L, Moyer L, Hewitt
K and Wells A: A novel treatment approach to the novel coronavirus:
An argument for the use of therapeutic plasma exchange for
fulminant COVID-19. Crit Care. 24(128)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Khamis F, Al-Zakwani I, Al Hashmi S, Al
Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H and Memish Z:
Therapeutic plasma exchange in adults with severe COVID-19
infection. Int J Infect Dis. 99:214–218. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gucyetmez B, Atalan HK, Sertdemir I, Cakir
U and Telci L: COVID-19 Study Group. Therapeutic plasma exchange in
patients with COVID-19 pneumonia in intensive care unit: A
retrospective study. Crit Care. 24(492)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sarfraz A, Makkar SS, Sarfraz Z, Hathaway
III D, Paul T, Sana MK, Talalaev M, Perez-Fernandez J and Yatzkan
G: Therapeutic plasma exchange and COVID-19: A rapid review. J Clin
Immunol Immunother. 6(041)2020.
|
|
17
|
Balagholi S, Dabbaghi R, Eshghi P, Mousavi
SA, Heshmati F and Mohammadi S: Potential of therapeutic
plasmapheresis in treatment of COVID-19 patients:
Immunopathogenesis and coagulopathy. Transfus Apher Sci.
59(102993)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kamran SM, Mirza ZE, Naseem A, Liaqat J,
Fazal I, Alamgir W, Saeed F, Saleem S, Nisar S, Yousaf MA, et al:
Therapeutic plasma exchange for coronavirus disease-2019 triggered
cytokine release syndrome; a retrospective propensity matched
control study. PLoS One. 16(e0244853)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu STH, Lin HM, Baine I, Wajnberg A,
Gumprecht JP, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A,
Bander J, et al: Convalescent plasma treatment of severe COVID-19:
A matched control study. Nat Med. 26:1708–1713. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xia X, Li K, Wu L, Wang Z, Zhu M, Huang B,
Li J, Wang Z, Wu W, Wu M, et al: Improved clinical symptoms and
mortality among patients with severe or critical COVID-19 after
convalescent plasma transfusion. Blood. 136:755–759.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jaiswal V, Nasa P, Raouf M, Gupta M,
Dewedar H, Mohammad H, Al Rais Z, Ali Baqer M, Alsabbah A, Ibrahim
Y, et al: Therapeutic plasma exchange followed by convalescent
plasma transfusion in critical COVID-19-an exploratory study. Int J
Infect Dis. 102:332–334. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Stahl K, Bode C and David S: First do no
harm-beware the risk of therapeutic plasma exchange in severe
COVID-19. Crit Care. 24(363)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Honore PM, Barreto Gutierrez L, Kugener L,
Redant S, Attou R, Gallerani A and De Bels D: Plasma exchange in
critically ill COVID-19 patients improved inflammation,
microcirculatory clot formation, and hypotension, thereby improving
clinical outcomes: Fact or fiction? Crit Care.
24(551)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Focosi D, Maggi F, Franchini M, Aguzzi A,
Lanza M, Mazzoni A and Menichetti F: Patient-blood management for
COVID19 convalescent plasma therapy: Relevance of affinity and
donor-recipient differences in concentration of neutralizing
antibodies. Clin Microbiol Infect. 27:987–992. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang EY, Mao T, Klein J, Dai Y, Huck JD,
Jaycox JR, Liu F, Zhou T, Israelow B, Wong P, et al: Diverse
functional autoantibodies in patients with COVID-19. Nature.
595:283–288. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fajnzylber J, Regan J, Coxen K, Corry H,
Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo
C, et al: SARS-CoV-2 viral load is associated with increased
disease severity and mortality. Nat Commun. 11(5493)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vuitton DA, Vuitton L, Seillès E and
Galanaud P: A plea for the pathogenic role of immune complexes in
severe Covid-19. Clin Immunol. 217(108493)2020.PubMed/NCBI View Article : Google Scholar
|
